ArticleActa dermato-venereologica2025

Efficacy and Safety of Abrocitinib in an Elderly Chinese Population with Moderate-to-Severe Atopic Dermatitis: A Non-randomized Controlled Trial.

Quanhong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.